$12.36
0.635.37%
Last update: Nov 4, 12:12 PM
AngioDynamics Inc
ANGONASDAQ
AngioDynamics (ANGO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
AngioDynamics (ANGO) last issued guidance on October 8, 2026 for fiscal year 2027. The company guided earnings per share in the range of $-0.29 - $-0.24, compared to a consensus EPS estimate of $-0.26. AngioDynamics also guided revenue in the range of $336M - $341M for the period.
Compared to prior guidance, AngioDynamics maintained its EPS outlook from a previous range of $-0.29 - $-0.24. On the revenue side, the company maintained its revenue forecast from a prior range of $336M - $341M.
AngioDynamics has issued 18 guidance updates between January 5, 2023 and October 8, 2026. During this period, the company raised its outlook 7 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.11 | $-0.09 | $-0.11 | $-0.10 |
| Actual | $-0.04 | $-0.07 | $-0.07 | $0.00 |
| Surprise | +63.6% | +22.2% | +36.4% | +100.0% |
| Revenue | ||||
| Estimate | $80.6M | $80.3M | $77.0M | $76.3M |
| Actual | $80.9M | $86.6M | $78.4M | $79.4M |
| Surprise | +0.41% | +7.87% | +1.83% | +4.13% |
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.08 | $-0.09 | $-0.02 | $-0.09 |
| Revenue | ||||
| Consensus | $83.9M | $83.4M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | Oct 8, 2026 | $-0.04 | $-0.11 | 63.6 % |
| Q4 | Jul 14, 2026 | $-0.07 | $-0.09 | 22.2 % |
| Q3 | Apr 2, 2026 | $-0.07 | $-0.11 | 36.4 % |
| Q2 | Jan 6, 2026 | $0 | $-0.10 | 100.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | Oct 8, 2026 | $80.92M | $80.59M | 0.41 % |
| Q4 | Jul 14, 2026 | $86.61M | $80.29M | 7.87 % |
| Q3 | Apr 2, 2026 | $78.42M | $77.01M | 1.83 % |
| Q2 | Jan 6, 2026 | $79.43M | $76.28M | 4.13 % |
